AI improves detail, estimate of urban air pollution

Using artificial intelligence, Cornell engineers have simplified models that accurately gauge the fine particulate matter in urban air pollution – exhaust from cars and trucks that get into human lungs. 

Method precisely locates gene activity and proteins across tissues

A new method can illuminate the identities and activities of cells throughout an organ or a tumor at unprecedented resolution, according to a study co-led by researchers at Weill Cornell Medicine and the New York Genome Center.

Enzyme that protects against viruses could fuel cancer evolution

The finding suggests that the enzyme may be a potential target for future cancer treatments.

Study identifies four major subtypes of long COVID

The researchers used a machine-learning algorithm to spot symptom patterns in the health records of nearly 35,000 U.S. patients who tested positive for SARS-CoV-2 infection and later developed lingering long-COVID-type symptoms.

Queens building aims to ease housing, health crisis in NYC

The Tree of Life Center – with 174 units, community and retail space, and a full-service health center and dental clinic – opened on Dec. 9 in Jamaica, Queens.

Shielding likely reduced COVID exposure for pregnant people early in pandemic

Those already pregnant at the beginning of the pandemic had a 50% lower exposure to SARS-CoV-2 compared with those who became pregnant after the pandemic began and the general population, Weill Cornell researchers and colleagues found.

Potential therapy for aggressive type of colon cancer shows promise

An experimental therapy showed promise as treatment for an aggressively spreading type of colorectal cancer in preclinical models, according to a new study by Weill Cornell Medicine investigators.

Freedom on the Move project inspires music performances

A Cornell-based database of “runaway ads” placed by enslavers in 18th- and 19th-century U.S. newspapers was the starting point for a new song cycle entitled “Songs in Flight” that will premiere Jan. 12 at the Metropolitan Museum of Art in New York City.

NIH funds antibiotic trial for HIV and emphysema

Weill Cornell Medicine has been awarded a five-year, $7.8 million grant from the National Heart, Lung, and Blood Institute to study whether the antibiotic doxycycline may slow the progression of emphysema in people living with well-controlled HIV.